SE382053B - Forfarande for framstellning av bifenylylalkanoylaminopyridiner - Google Patents

Forfarande for framstellning av bifenylylalkanoylaminopyridiner

Info

Publication number
SE382053B
SE382053B SE7306900A SE7306900A SE382053B SE 382053 B SE382053 B SE 382053B SE 7306900 A SE7306900 A SE 7306900A SE 7306900 A SE7306900 A SE 7306900A SE 382053 B SE382053 B SE 382053B
Authority
SE
Sweden
Prior art keywords
bifenylyl
alkanoylaminopyridines
procedure
preparation
bifenylyl alkanoylaminopyridines
Prior art date
Application number
SE7306900A
Other languages
English (en)
Swedish (sv)
Inventor
F Tenconi
R Tagliabue
L Molteni
Original Assignee
Zambeletti Spa L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambeletti Spa L filed Critical Zambeletti Spa L
Publication of SE382053B publication Critical patent/SE382053B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7306900A 1972-05-23 1973-05-16 Forfarande for framstellning av bifenylylalkanoylaminopyridiner SE382053B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24732/72A IT1044222B (it) 1972-05-23 1972-05-23 Bifenilil alcanoilaminopiridine ad attivita anti infiammatoria di lunga durata

Publications (1)

Publication Number Publication Date
SE382053B true SE382053B (sv) 1976-01-12

Family

ID=11214555

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7306900A SE382053B (sv) 1972-05-23 1973-05-16 Forfarande for framstellning av bifenylylalkanoylaminopyridiner

Country Status (19)

Country Link
US (1) US3868380A (hu)
JP (1) JPS5429508B2 (hu)
AR (1) AR196130A1 (hu)
AU (1) AU469305B2 (hu)
BE (1) BE799841A (hu)
BR (1) BR7303772D0 (hu)
CA (1) CA978970A (hu)
CH (1) CH605766A5 (hu)
DD (1) DD108083A5 (hu)
DK (1) DK142948C (hu)
ES (1) ES415000A1 (hu)
FR (1) FR2185410B1 (hu)
GB (1) GB1380225A (hu)
IT (1) IT1044222B (hu)
LU (1) LU67624A1 (hu)
NL (1) NL151366B (hu)
NO (1) NO138999C (hu)
SE (1) SE382053B (hu)
YU (1) YU35243B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2465723A1 (fr) * 1979-05-30 1981-03-27 Italiana Schoum Spa Nouvelles diphenylpropylamino-pyridines utilisables comme medicaments
FR2514355A1 (fr) * 1981-10-14 1983-04-15 Fabre Sa Pierre Derives de biphenyl alcoyl carboxylates, leur procede de preparation et leur utilisation comme medicaments
US4600649A (en) * 1984-10-22 1986-07-15 Desoto, Inc. Abrasion-resistant ultraviolet-curable coatings
US7968574B2 (en) * 2004-12-28 2011-06-28 Kinex Pharmaceuticals, Llc Biaryl compositions and methods for modulating a kinase cascade
ATE544748T1 (de) 2004-12-28 2012-02-15 Kinex Pharmaceuticals Llc Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
CA2656564C (en) * 2006-06-29 2015-06-16 Kinex Pharmaceuticals, Llc Biaryl compositions and methods for modulating a kinase cascade
TWI457336B (zh) * 2006-12-28 2014-10-21 Kinex Pharmaceuticals Llc 調節激酶級聯之組成物及方法
US7939529B2 (en) * 2007-05-17 2011-05-10 Kinex Pharmaceuticals, Llc Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
US7935697B2 (en) * 2006-12-28 2011-05-03 Kinex Pharmaceuticals, Llc Compositions for modulating a kinase cascade and methods of use thereof
US8124605B2 (en) * 2007-07-06 2012-02-28 Kinex Pharmaceuticals, Llc Compositions and methods for modulating a kinase cascade
WO2009051848A1 (en) * 2007-10-20 2009-04-23 Kinex Pharmaceuticals, Llc Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
CA2796419C (en) 2010-04-16 2018-11-06 Kinex Pharmaceuticals, Llc Compositions and methods for the prevention and treatment of cancer
TWI664167B (zh) 2012-08-30 2019-07-01 美商艾瑟奈克斯公司 用於調節激酶級聯之組成物及方法
JP7319977B2 (ja) * 2017-12-06 2023-08-02 リン バイオサイエンス,インコーポレイテッド チューブリン阻害剤
EP4230196A1 (en) 2022-02-21 2023-08-23 Som Innovation Biotech, S.A. Compounds for use in the treatment of dystrophinopathies

Also Published As

Publication number Publication date
FR2185410B1 (hu) 1976-05-14
AU469305B2 (en) 1976-02-12
AU5583373A (en) 1974-11-21
NL151366B (nl) 1976-11-15
BE799841A (fr) 1973-09-17
DD108083A5 (hu) 1974-09-05
NL7307114A (hu) 1973-11-27
GB1380225A (en) 1975-01-08
BR7303772D0 (pt) 1974-08-29
CH605766A5 (hu) 1978-10-13
AR196130A1 (es) 1973-11-30
DK142948C (da) 1981-10-05
CA978970A (en) 1975-12-02
NO138999B (no) 1978-09-11
DE2325309A1 (de) 1973-12-06
YU35243B (en) 1980-10-31
NO138999C (no) 1978-12-20
JPS4948676A (hu) 1974-05-11
DE2325309B2 (de) 1976-01-29
YU133872A (en) 1980-04-30
ES415000A1 (es) 1976-06-01
DK142948B (da) 1981-03-02
JPS5429508B2 (hu) 1979-09-25
FR2185410A1 (hu) 1974-01-04
LU67624A1 (hu) 1973-08-02
US3868380A (en) 1975-02-25
IT1044222B (it) 1980-03-20

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE414025B (sv) Forfarande for framstellning av fototropa flerfokala glasogonglas
SE389856B (sv) Forfarande for framstellning av alkaliperkarbonater
SE416176B (sv) Forfarande for framstellning av hogdoserade autibiotikatabletter
SE404525B (sv) Forfarande for framstellning av 4-aminometyl-cyklohexan-karboxylsyra-1
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
NO136750C (no) Fremgangsm}te for fremstilling av indanderivater
AR197040A1 (es) Procedimiento de preparacion de nuevas bifenilacetamidas
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
NO139086C (no) R fremgangsmaate for fremstilling av benzensulfonylurinstoffe
IT996099B (it) Procedimento di preparazione di amminoantrachinone
AR205791A1 (es) Procedimiento de preparacion de sulfobenzo lactamas
SE408643B (sv) Forfarande for framstellning av morfantridiner
SE396377B (sv) Forfarande for framstellning av difenylmetoxietylaminer